CoChat

Economic Evaluation alongside a Phase II, Multi-Centre, Randomised Controlled Trial of Very Early Rehabilitation after Stroke (AVERT)

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Background/Purpose: The effectiveness and costs of very early rehabilitation after stroke are unknown. This study assessed the cost effectiveness of very early mobilisation in addition to standard care (VEM) compared with standard care alone (SC). Methods: Cost-effectiveness analysis alongside a phase II, multi-centre, randomised controlled trial (RCT) with blinded outcome assessments. Less than 24 h after stroke, patients were recruited from two stroke units and randomised to receive VEM or SC. The intervention continued until discharge or 14 days, whichever was sooner. The efficacy measure was a dichotomised modified Rankin Scale (mRS) at 3 months with mRS ≤2 representing good outcome. Costs were determined from medical records and patient interviews at 3, 6 and 12 months. National average (where available) or local costs were applied for the reference year 2004. Differences in mean total costs at 3 and 12 months were tested using t test assuming unequal variances. An incremental cost-effectiveness ratio was calculated and probabilistic uncertainty analysis was undertaken. Results: The sample consisted of 38 VEM and 33 SC patients. A trend for good outcome with VEM compared to SC was found (adjusted OR 4.10, 95% CI 0.99–16.88, p = 0.051). Patients receiving VEM incurred significantly less costs at 3 months (AUD 13,559) compared with SC (AUD 21,860; p = 0.02). This difference in mean per patient total cost persisted at the 12-month assessment (VEM: AUD 17,564; SC: AUD 29,750; p = 0.03). VEM was found to be a ‘dominant’ (more effective, less cost) intervention when compared to SC at 3 months. Conclusion: These findings provide preliminary evidence that VEM is likely to be cost-effective. A large RCT is currently underway to confirm the cost effectiveness of VEM.

Overview

Integrity signals

Registry

Crossref · 10.1159/000155984

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 67

Metadata

Authors
Tay-Teo, K., Moodie, M., Bernhardt, J., Thrift, A. G., Collier, J., Donnan, G., & Dewey, H.
Affiliations
  • The University of Melbourne (AU)
  • Deakin University (AU)
  • The Alfred Hospital (AU)
  • Florey Institute of Neuroscience and Mental Health (AU)
Venue
Cerebrovascular Diseases
Publisher
S. Karger AG
Published
2008
Volume
26
Issue
5
Pages
475-481
ISSN
  • 1015-9770 (ISSN-L)
  • 1421-9786
OpenAlex
W2048025423
Cited by
67
References
15
Citations by year
2024: 12 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 4 · 2016: 3 · 2015: 6 · 2014: 7 · 2013: 6 · 2012: 8
FWCI
3.56
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Cerebrovascular Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Rehabilitation › Stroke Rehabilitation and Recovery
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Keywords
stroke, early rehabilitation, cost-effectiveness, modified Rankin Scale, stroke recovery, health care costs
MeSH terms
Stroke Rehabilitation, Aged, Australia, Cost-Benefit Analysis, Early Ambulation, Female, Health Services, Humans, Male, Middle Aged, Time Factors, Odds Ratio, Treatment Outcome, Cost Savings, Health Care Costs, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.